TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Gland Pharma Ltd.

GLAND on NSE · 19 Nov 2026

NIFTY 500

3,292.90 ▲ +1.93 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Balance sheet

What the company owns and owes, as reported.

₹ cr30 Sep 202631 Mar 202630 Sep 202531 Mar 202530 Sep 202431 Mar 2024
Total assets12,92712,51111,80011,22510,86710,661
Equity attributable to owners10,68610,3589,5639,1518,7888,724
Current borrowings156173181192185213
Non-current borrowings6370747894107
Cash and cash equivalents3,4413,3592,7042,5562,820357

Cash flow

Where the cash came from and went, by financial year.

₹ crYear to Mar 2026Year to Mar 2025Year to Mar 2024Year to Mar 2023Year to Mar 2022
Cash flow from operating activities1,031915997364791
Cash flow from investing activities1381,705-1,7571,208-1,003
Cash flow from financing activities-417-433-7991535
Purchase of property, plant and equipment491385390221511

Figures are consolidated, in ₹ cr unless the line is a percentage, from the company's results filed with NSE. Companies report a balance sheet twice a year and cash flow for the year to date; a dash means the line was not reported.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in